id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0224-0019,FDA,FDA-2000-N-0224,OMB Review re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Proposed Rule,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:44:32Z,,0,0,09000064804d5424
FDA-2000-N-0224-0020,FDA,FDA-2000-N-0224,Tab A: Draft of FRN 67FR22367 Publication Date: 05/03/2002 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:44:11Z,,0,0,09000064804d5427
FDA-2000-N-0224-0022,FDA,FDA-2000-N-0224,OMB Review re: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Notice of Proposed Rule Making,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:43:11Z,,0,0,09000064804d542b
FDA-2000-N-0224-0021,FDA,FDA-2000-N-0224,Tab B: Draft of FRN 67FR22367 Publication Date: 05/03/2002 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:43:48Z,,0,0,09000064804d5423
FDA-2000-N-0224-0024,FDA,FDA-2000-N-0224,Tab A: Draft of FRN 68FR69009 Publication Date: 12/11/2003 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:42:42Z,,0,0,09000064804d5426
FDA-2000-N-0224-0025,FDA,FDA-2000-N-0224,Tab B: Draft of FRN 68FR69009 Publication Date: 12/11/2003 to OMB,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:42:18Z,,0,0,09000064804d5422
FDA-2000-N-0224-0023,FDA,FDA-2000-N-0224,OMB Review: Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format; Final Rule,Supporting & Related Material,Background Material,2015-11-17T05:00:00Z,2015,11,,,2015-12-09T14:16:13Z,,0,0,09000064804d5425